FTC targets child supplement claims
This article was originally published in The Tan Sheet
Manufacturers of dietary supplements carrying health claims for children "can expect to see more [advertising regulatory] activity in this area" in the near future, Federal Trade Commission Associate Director for Advertising Practices Mary Engle says at American Herbal Products Association members breakfast Sept. 4. Engle attributes "grave concern" in Congress about dietary supplement advertising to children as spurring likely upcoming FTC actions. The House Energy & Commerce/Oversight & Investigations Subcommittee discussed legislation to give FDA more access to dietary supplement safety information and greater leniency to protect consumers from potentially unsafe products at July 23 meeting (1"The Tan Sheet" July 28, 2003, p. 3)...
You may also be interested in...
Reps. Henry Waxman (D-Calif.) and Susan Davis (D-Calif.) are working on legislation "that will give FDA greater access to information to understand if a [dietary supplement] product does pose a health risk and will let FDA protect consumers from unsafe products," Waxman said at a July 23 hearing of the House Energy & Commerce/Oversight & Investigations Subcommittee
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.